Alerts will be sent to your verified email
Verify Email
ADVIKLA
|
MPS Pharmaa
|
Kobo Biotech
|
Hind Bio Science
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-55.68 % | -1.77 % | -24.99 % |
|
5yr average Equity Multiplier
|
4.57 | 4.06 | 3.76 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.54 | 0.25 |
|
5yr Avg Net Profit Margin
|
-87.46 % | -3.79 % | -39.56 % |
|
Price to Book
|
6.2 | 0.0 | 5.81 |
|
P/E
|
0.0 | 0.0 | 245.53 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 197.57 Days |
|
Inventory Days
|
1258.79 Days | 89.28 Days | 0.0 |
|
Days Receivable
|
0.0 | 0.0 | 198.39 Days |
|
Days Payable
|
414.72 Days | 147.48 Days | 104.32 Days |
|
5yr Average Interest Coverage Ratio
|
-777.17 | 0.99 | -32.49 |
|
5yr Avg ROCE
|
-52.41 % | 11.79 % | -14.28 % |
|
5yr Avg Operating Profit Margin
|
-415.88 % | 8.83 % | -38.68 % |
|
5 yr average Debt to Equity
|
3.19 | 1.62 | 2.68 |
|
5yr CAGR Net Profit
|
-27.26 % | n/a | n/a |
|
5yr Average Return on Assets
|
-13.75 % | -0.89 % | -8.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.89 % | 44.95 % | 12.19 % |
|
Share Pledged by Promoters
|
16.04 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
MPS Pharmaa
|
Kobo Biotech
|
Hind Bio Science
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|